An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease

F Maltais, M Decramer, R Casaburi… - American journal of …, 2014 - atsjournals.org
Background: Limb muscle dysfunction is prevalent in chronic obstructive pulmonary disease
(COPD) and it has important clinical implications, such as reduced exercise tolerance …

Skeletal muscle dysfunction in chronic obstructive pulmonary disease. What we know and can do for our patients

A Jaitovich, E Barreiro - American journal of respiratory and critical …, 2018 - atsjournals.org
Skeletal muscle dysfunction occurs in patients with chronic obstructive pulmonary disease
(COPD) and affects both ventilatory and nonventilatory muscle groups. It represents a very …

Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease

M Divo, C Cote, JP de Torres, C Casanova… - American journal of …, 2012 - atsjournals.org
Rationale: Patients with chronic obstructive pulmonary disease (COPD) are afflicted by
comorbidities. Few studies have prospectively evaluated COPD comorbidities and mortality …

Chronic kidney disease and premature ageing

JP Kooman, P Kotanko, AMWJ Schols… - Nature Reviews …, 2014 - nature.com
Chronic kidney disease (CKD) shares many phenotypic similarities with other chronic
diseases, including heart failure, chronic obstructive pulmonary disease, HIV infection and …

[PDF][PDF] Mechanisms modulating skeletal muscle phenotype

B Blaauw, S Schiaffino, C Reggiani - Compr Physiol, 2013 - researchgate.net
Mammalian skeletal muscles are composed of a variety of highly specialized fibers whose
selective recruitment allows muscles to fulfill their diverse functional tasks. In addition …

Role of β-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease

GS Lynch, JG Ryall - Physiological reviews, 2008 - journals.physiology.org
The importance of β-adrenergic signaling in the heart has been well documented, but it is
only more recently that we have begun to understand the importance of this signaling …

The preclinical pharmacology of roflumilast–a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease

A Hatzelmann, EJ Morcillo, G Lungarella… - Pulmonary …, 2010 - Elsevier
After more than two decades of research into phosphodiesterase 4 (PDE4) inhibitors,
roflumilast (3-cyclopropylmethoxy-4-difluoromethoxy-N-[3, 5-di-chloropyrid-4-yl]-benzamide) …

Epidemiology of chronic obstructive pulmonary disease: prevalence, morbidity, mortality, and risk factors

SR Rosenberg, R Kalhan… - Seminars in respiratory …, 2015 - thieme-connect.com
Chronic obstructive pulmonary disease (COPD) remains a common and important cause of
morbidity and mortality both in the United States and globally. The increasing trends of …

[HTML][HTML] Peripheral muscle abnormalities in cystic fibrosis: Etiology, clinical implications and response to therapeutic interventions

M Gruet, T Troosters, S Verges - Journal of Cystic Fibrosis, 2017 - Elsevier
Peripheral muscle dysfunction is an important systemic consequence of cystic fibrosis (CF)
with major clinical implications, such as exercise intolerance and reduced quality of life …

Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony

AE Mirrakhimov - Cardiovascular diabetology, 2012 - Springer
Chronic obstructive pulmonary disease, metabolic syndrome and diabetes mellitus are
common and underdiagnosed medical conditions. It was predicted that chronic obstructive …